Review Article
Volume 5 Issue 7 - 2020
Chronic Heart Failure in Insulin-Treated Patients with Type 2 Diabetes Mellitus: A Systematic Review of Clinical Trials
Meshael Meshal Aljoaid1*, Ramzi Ibrahim Alsulami2, Saeed Saleh Nazih3, Hassan Abdulwahab Aljifri4, Ali Naji Al Nihab5, Turki Sanat Al Harbi6, Raed Fahad Almutairi7, Yusuf Salh Allehaidan8 and Musaab Khalil Albalawi9
1Primary Health Center, Ministry of Health, Taif, Saudi Arabia
2College of Medicine, King Abdulaziz University, Saudi Arabia
3College of Medicine, King Khalid University, Abha, Saudi Arabia
4College of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia
5Department of Emergency Medicine, Anak General Hospital, Eastern Province, Saudi Arabia
6College of Medicine, Shaqra University, Shaqra, Saudi Arabia
7Administration of Specialized Centers and Visiting Doctors, Ministry of Health, Riyadh, Saudi Arabia
8Department of Nephrology and Health Affairs, King Saud Medical City, Riyadh, Saudi Arabia
9Alsharqiyah Primary Health Care Center, Ministry of Health, Yanbu, Saudi Arabia
*Corresponding Author: Meshael Meshal Aljoaid, Primary Health Center, Ministry of Health, Taif, Saudi Arabia.
Received: June 12, 2020; Published: June 23, 2020




Abstract

It is well established that there is a reciprocal association between heart failure (HF) and type 2 diabetes mellitus (DM). In the current study, we aim to give an overview of chronic HF in insulin-treated patients with type 2 diabetes mellitus. For that, we conducted a systematic electronic database search for suitable studies from inception till 8th June 2020 in seven databases. We included all relevant randomized controlled studies (RCTs) reporting insulin-related chronic HF in patients with type 2 diabetes mellitus. Finally, we included five papers in this systematic review. Patients allocated to Insulin + sulphonylurea had a higher risk of HF with an incidence of 8% compared to 3.6% of patients allocated to conventional treatment. Of patients receiving pioglitazone 45 mg + insulin or pioglitazone 30 mg + insulin, 4 patients experienced HF with an incidence of 1%. For Balaglitazone 20 mg + insulin group or the placebo group, the incidence was 2%, while it was 0% for patients received Balaglitazone 10 mg + insulin. No significant difference was observed between HF hospitalization rates between patients randomized to insulin glargine or standard care (0.63). In conclusion, close monitoring of heart pathologies-especially heart failure- in type 2 DM patients is of extreme importance for improving the quality and expectancy of life in those patients.

Keywords: Insulin; Heart Failure; Diabetes Mellitus

References

  1. Kannel WB., et al. "Role of Diabetes in Congestive Heart Failure: The Framingham Study”. The American Journal of Cardiology 1 (1974): 29-34.
  2. Nichols GA., et al. "Congestive Heart Failure in Type 2 Diabetes: Prevalence, Incidence, and Risk Factors”. Diabetes Care 9 (2001): 1614-1619.
  3. "Age- and Sex-Specific Prevalences of Diabetes and Impaired Glucose Regulation in 13 European Cohorts”. Diabetes Care 1 (2003): 61-69.
  4. Held C., et al. "Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk”. Circulation11 (2007): 1371-1375.
  5. Kristensen SL., et al. "Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure with Reduced Ejection Fraction: Insights from Prospective Comparison of Arni with Acei to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial”. Circulation Heart Failure 1 (2016).
  6. Kristensen SL., et al. "Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients with Heart Failure and Preserved Ejection Fraction: A Report from the I-Preserve Trial (Irbesartan in Heart Failure with Preserved Ejection Fraction)”. Circulation8 (2017): 724-735.
  7. MacDonald MR., et al. "Diabetes, Left Ventricular Systolic Dysfunction, and Chronic Heart Failure”. European Heart Journal 10 (2008): 1224-1240.
  8. MacDonald MR., et al. "Impact of Diabetes on Outcomes in Patients with Low and Preserved Ejection Fraction Heart Failure: An Analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (Charm) Programme”. European Heart Journal 11 (2008): 1377-1385.
  9. Miettinen Heikki., et al. "Impact of Diabetes on Mortality after the First Myocardial Infarction”. Diabetes Care1 (1998): 69-75.
  10. Dries DL., et al. "Prognostic Impact of Diabetes Mellitus in Patients with Heart Failure According to the Etiology of Left Ventricular Systolic Dysfunction”. Journal of the American College of Cardiology 2 (2001): 421-428.
  11. Riehle Christian and E Dale Abel. "Insulin Signaling and Heart Failure”. Circulation Research7 (2016): 1151-1169.
  12. Wang Y., et al. "Prediction of Heart Failure in Patients with Type 2 Diabetes Mellitus- a Systematic Review and Meta-Analysis”. Diabetes Research and Clinical Practice 1 (2015): 55-66.
  13. Nagoshi Tomohisa., et al. "Optimization of Cardiac Metabolism in Heart Failure”. Current Pharmaceutical Design 17.35 (2011): 3846-3853.
  14. Rosano GM., et al. "Cardiac Metabolism in Myocardial Ischemia”. Current Pharmaceutical Design 25 (2008): 2551-2562.
  15. Rosano Giuseppe Mc., et al. "Heart Failure in Patients with Diabetes Mellitus”. Cardiac Failure Review1 (2017): 52-55.
  16. Gilbert RE and H Krum. "Heart Failure in Diabetes: Effects of Anti-Hyperglycaemic Drug Therapy”. Lancet9982 (2015): 2107-2117.
  17. McMurray JJ., et al. "Heart Failure: A Cardiovascular Outcome in Diabetes That Can No Longer Be Ignored”. The Lancet Diabetes and Endocrinology 10 (2014): 843-851.
  18. Bozkurt B., et al. "Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus Hyperlipidemia and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement from the American Heart Association”. Circulation23 (2016): e535-e578.
  19. DeFronzo RA., et al. "The Effect of Insulin on Renal Handling of Sodium, Potassium, Calcium, and Phosphate in Man”. Journal of Clinical Investigation 4 (1975): 845-855.
  20. Skøtt P., et al. "Effects of Insulin on Kidney Function and Sodium Excretion in Healthy Subjects”. Diabetologia9 (1989): 694-699.
  21. Cosmi F., et al. "Insulin Therapy May Hasten Congestive Heart Failure in Cardiac Patients: Case Series and Review of the Literature”. Giornale Italiano Di Cardiologia7 (2008): 509-512.
  22. Felker GM., et al. "Loop Diuretics in Acute Decompensated Heart Failure: Necessary? Evil? A Necessary Evil?" Circulation Heart Failure 1 (2009): 56-62.
  23. Cosmi Franco., et al. "Treatment with Insulin Is Associated with Worse Outcome in Patients with Chronic Heart Failure and Diabetes”. European Journal of Heart Failure 5 (2018): 888-895.
  24. Liberati Alessandro., et al. "The Prisma Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration”. PLoS Medicine 7 (2009): e1000100.
  25. Vassar Matt., et al. "Manual Search Approaches Used by Systematic Reviewers in Dermatology”. Journal of the Medical Library Association: JMLA 4 (2016): 302.
  26. Higgins Julian PT., et al. "The Cochrane Collaboration’s Tool for Assessing Risk of Bias in Randomised Trials”. British Medical Journal 343 (2011).
  27. Davidson JA., et al. "Addition of Pioglitazone to Stable Insulin Therapy in Patients with Poorly Controlled Type 2 Diabetes: Results of a Double-Blind, Multicentre, Randomized Study”. Diabetes, Obesity and Metabolism 2 (2006): 164-174.
  28. Henriksen K., et al. "Efficacy and Safety of the Pparγ Partial Agonist Balaglitazone Compared with Pioglitazone and Placebo: A Phase Iii, Randomized, Parallel-Group Study in Patients with Type 2 Diabetes on Stable Insulin Therapy”. Diabetes/Metabolism Research and Reviews 4 (2011): 392-401.
  29. "Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (Ukpds 33). Uk Prospective Diabetes Study (Ukpds) Group”. Lancet9131 (1998): 837-853.
  30. Pratley RE., et al. "Heart Failure with Insulin Degludec Versus Glargine U100 in Patients with Type 2 Diabetes at High Risk of Cardiovascular Disease: Devote 14”. Cardiovascular Diabetology 1 (2019): 156.
  31. "Cardiovascular and Other Outcomes Postintervention with Insulin Glargine and Omega-3 Fatty Acids (Originale)”. Diabetes Care5 (2016): 709-716.
  32. Packer Milton. "Heart Failure: The Most Important, Preventable, and Treatable Cardiovascular Complication of Type 2 Diabetes”. Diabetes Care1 (2018): 11-13.
  33. Aronow Wilbert S and Chul Ahn. "Incidence of Heart Failure in 2,737 Older Persons with and without Diabetes Mellitus”. Chest3 (1999): 867-868.
  34. Levy Daniel., et al. "The Progression from Hypertension to Congestive Heart Failure”. The Journal of the American Medical Association 20 (1996): 1557-1562.
  35. Fuller John H. "Epidemiology of Hypertension Associated with Diabetes Mellitus”. Hypertension6-2 (1985): II3.
  36. Iribarren Carlos., et al. "Glycemic Control and Heart Failure among Adult Patients with Diabetes”. Circulation22 (2001): 2668-2673.
  37. Von Bibra Helene and Martin St John Sutton. "Impact of Diabetes on Postinfarction Heart Failure and Left Ventricular Remodeling”. Current Heart Failure Reports4 (2011): 242.
  38. Delea Thomas E., et al. "Use of Thiazolidinediones and Risk of Heart Failure in People with Type 2 Diabetes: A Retrospective Cohort Study”. Diabetes Care11 (2003): 2983-2989.
  39. McAlister Finlay A., et al. "The Risk of Heart Failure in Patients with Type 2 Diabetes Treated with Oral Agent Monotherapy”. European Journal of Heart Failure7 (2008): 703-708.
  40. Zannad Faiez., et al. "Heart Failure and Mortality Outcomes in Patients with Type 2 Diabetes Taking Alogliptin Versus Placebo in Examine: A Multicentre, Randomised, Double-Blind Trial”. The Lancet9982 (2015): 2067-2076.
  41. Smooke Stephanie Tamara B Horwich and Gregg C Fonarow. "Insulin-Treated Diabetes Is Associated with a Marked Increase in Mortality in Patients with Advanced Heart Failure”. American Heart Journal1 (2005): 168-174.
  42. Group UK Prospective Diabetes Study. "Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (Ukpds 33)”. The Lancet9131 (1998): 837-853.
  43. Kim MK., et al. "2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea”. Diabetes and Metabolism Journal 4 (2019): 398-406.
  44. Muscelli Elza., et al. "Effect of Insulin on Renal Sodium and Uric Acid Handling in Essential Hypertension”. American Journal of Hypertension8 (1996): 746-752.
  45. Patel Tushar P., et al. "Insulin Resistance: An Additional Risk Factor in the Pathogenesis of Cardiovascular Disease in Type 2 Diabetes”. Heart Failure Reviews1 (2016): 11-23.
Citation: Meshael Meshal Aljoaid., et al.. “Chronic Heart Failure in Insulin-Treated Patients with Type 2 Diabetes Mellitus: A Systematic Review of Clinical Trials”. EC Microbiology 16.7 (2020): 58-65.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for September Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the September issue of respective journals. Submissions are accepted on/before August 15, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk